GlobeStar Therapeutics Corp (GSTC) Cash flow
Market cap
$124.11K
P/E ratio
| 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | |
| Stock-based compensation | - | 307,717 | - | 68,250 | 35,500 | 8 | 322,266 | 464,878 |
| Cash from operations | -29,996 | -53,745 | -180,091 | -260,138 | -239,735 | -751,232 | -326,995 | -205,760 |
| Capital expenditures | - | - | -1,412 | - | -1,782 | - | - | - |
| Cash from investing | 5,691 | - | -1,412 | - | -1,782 | - | - | - |
| Proceeds from issuance of term debt, net | 30,150 | 12,000 | - | - | - | - | - | - |
| Cash from financing | 30,150 | 62,000 | 259,000 | 269,000 | 222,500 | 675,750 | 327,400 | 199,395 |
| Free cash flow | - | - | - | - | - | |||
| FCF margin (%) | - | - | - | - | - |